Examkin

Soru

Zorluk: KolayGeneral Internal Medicine

A 65-year-old man is evaluated in the hospital on day 3 of admission for community-acquired pneumonia. He was initially started on empiric intravenous ceftriaxone and azithromycin. His past medical history is notable for hypertension and type 2 diabetes mellitus. Today, he reports feeling much better and has a good appetite. His temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 128/78 mmHg128/78\text{ mmHg}, pulse is 78/min78/\text{min}, and respiratory rate is 14/min14/\text{min}. Pulse oximetry shows 96%96\% on room air. Physical examination reveals significantly decreased crackles at the right lower lung base compared to admission. The patient is tolerating an oral diet. Blood cultures obtained on admission show no growth. A sputum culture obtained on admission has grown *Streptococcus pneumoniae*. Susceptibility testing indicates the organism is highly susceptible to penicillin, amoxicillin, ceftriaxone, and levofloxacin, but resistant to azithromycin. Which of the following is the most appropriate next step in the management of this patient?

  1. Transition to oral amoxicillinCevap
  2. B
    Transition to oral levofloxacin
  3. C
    Transition to oral amoxicillin-clavulanate
  4. D
    Continue intravenous ceftriaxone
  5. E
    Continue intravenous ceftriaxone and azithromycin

Cevap

Transition to oral amoxicillin
This patient was admitted for community-acquired pneumonia and has demonstrated significant clinical improvement. He is now afebrile, hemodynamically stable, and tolerating oral intake. According to the principles of antibiotic stewardship, patients who are clinically stable on intravenous antibiotics should be transitioned to oral therapy. Furthermore, the sputum culture has identified Streptococcus pneumoniae that is susceptible to penicillin and amoxicillin. The most appropriate action is to de-escalate (narrow the spectrum) from empiric ceftriaxone to targeted oral amoxicillin therapy to minimize collateral damage to the microbiome and reduce the risk of resistance.

Adım Adım Çözüm

1
Evaluate the patient's clinical stability and current route of administration.
The patient is afebrile, hemodynamically stable, improving clinically, and successfully tolerating an oral diet.
Clinical stability criteria determine if a patient is ready to transition safely from intravenous to oral antibiotic therapy.
2
Analyze the sputum culture and susceptibility results.
The responsible pathogen is Streptococcus pneumoniae, which is susceptible to narrow-spectrum beta-lactams like amoxicillin and penicillin.
De-escalation of broad-spectrum empiric therapy must be guided by final culture and sensitivity data.
3
Select the most appropriate targeted oral agent.
Oral amoxicillin is chosen as the definitive therapy.
It provides targeted, narrow-spectrum coverage against the identified pathogen, minimizes collateral damage to the patient's microbiome, and facilitates prompt hospital discharge.

Anahtar Kavram

Antibiotic stewardship principles mandate de-escalating broad-spectrum empiric therapy to targeted, narrow-spectrum oral agents once clinical stability is achieved and culture susceptibilities are known.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

General Internal Medicine

Bu konudan daha fazla soru